Clinic Roundup

 Cryopraxis Cryobiology Ltd., of Rio de Janeiro, Brazil, and affiliate CellPraxis, of São Paulo, Brazil, plan to begin patient recruitment for the Brazilian arm of a Phase III refractory angina cell therapy trial by the end of 2012 or early 2013.